Haba Laboratories Inc

Haba Laboratories Inc has a liquidity position that appears robust, with a current ratio of 3.23, indicating that the company holds more than three times as much in current assets as it does in current liabilities. The company's cash and equivalents amount to 3,959,197,000 JPY, which is a significant portion of its total assets of 12,431,193,000 JPY. However, the company's operating cash flow is negative at -587,921,000 JPY, which may signal challenges in generating cash from its core operations.

Profitability metrics for Haba Laboratories Inc are negative, with a return on equity of -14.18% and a return on assets of -9.71%. These figures are below the typical performance of the personal care products industry, which is expected to maintain positive returns given its consumer staples nature. The company's operating income is negative at -1,199,169,000 JPY, and its net income is also negative at -1,206,621,000 JPY. These results suggest that the company is currently unprofitable and may be facing operational inefficiencies or market challenges.

The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company is based in Japan, and there is no indication of significant international operations. This concentration may expose the company to regional economic fluctuations and regulatory changes specific to Japan.

Looking ahead, the company's growth trajectory is uncertain. The most recent actual revenue of 12,061,830,000 JPY is significantly lower than the reported revenue of 3,687,704,000 JPY, suggesting a potential discrepancy or a change in reporting periods. The company's capital expenditure of -433,282,000 JPY indicates that it is investing in its operations, but the negative operating cash flow may limit its ability to sustain such investments without external financing.

Risk factors for Haba Laboratories Inc include its negative profitability and operating cash flow, which could lead to increased reliance on external financing. The company's debt-to-equity ratio of 0.28 is relatively low, indicating a conservative capital structure. However, the risk assessment notes low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's capital structure appears to be stable, but its financial performance may require close monitoring.

Recent events and filings do not indicate any major changes in the company's operations or financial strategy. The company's last actual EPS was 152.47 JPY, and its last actual revenue was 12,061,830,000 JPY. These figures suggest that the company may have experienced a significant decline in revenue, which could be due to market conditions, operational issues, or changes in reporting periods.

Net income surged 31.9% year-over-year to 760 million JPY in fiscal 2025, marking a strong profitability recovery.

Free cash flow jumped 84.2% to 686 million JPY in fiscal 2025, demonstrating significantly improved cash generation capabilities.

Long-term debt decreased to 1.19 billion JPY in fiscal 2025, reflecting a disciplined approach to balance sheet deleveraging.

Operating income turned positive at 722 million JPY in fiscal 2025, reversing previous years of significant operating losses.

The company maintains low dilution and liquidity risks, providing a stable financial foundation for ongoing operations.

Operating and net margins remain in the bottom quartile of the Personal Products cohort, signaling severe competitive disadvantage.

The company faces high credit risk, posing a significant threat to its financial stability and borrowing capacity.

Cash conversion ratio of 0.49 is well below the cohort median of 0.97, highlighting inefficient working capital management.

Revenue ¥3.17B, +0,4% YoY; Operating income −2,9% YoY.

• ▍Revenue ¥3.17B, +0,4% YoY
• ▍Operating income −2,9% YoY
• ▍Net income −44,8% YoY
• ▍Net margin 4.1%

Revenue ¥2.92B, +4,9% YoY; Operating income +870,7% YoY.

• ▍Revenue ¥2.92B, +4,9% YoY
• ▍Operating income +870,7% YoY
• ▍Net income +2 114,0% YoY
• ▍Net margin 5.0%

Revenue ¥2.63B, −1,6% YoY; Operating income +261,7% YoY.

• ▍Revenue ¥2.63B, −1,6% YoY
• ▍Operating income +261,7% YoY
• ▍Net income +284,9% YoY
• ▍Net margin 1.6%

Revenue ¥3.45B, −6,4% YoY; Operating income +130,7% YoY.

• ▍Revenue ¥3.45B, −6,4% YoY
• ▍Operating income +130,7% YoY
• ▍Net income +129,5% YoY
• ▍Net margin 10.3%

Revenue ¥3.15B; Operating income ¥257.6M.

• ▍Revenue ¥3.15B
• ▍Operating income ¥257.6M
• ▍Net margin 7.5%

Revenue ¥2.79B; Operating income ¥19.9M.

• ▍Revenue ¥2.79B
• ▍Operating income ¥19.9M
• ▍Net margin 0.2%

Revenue ¥2.67B; Operating income -¥37.4M.

• ▍Revenue ¥2.67B
• ▍Operating income -¥37.4M
• ▍Net margin -0.8%

Revenue ¥3.69B; Operating income -¥1.20B.

• ▍Revenue ¥3.69B
• ▍Operating income -¥1.20B
• ▍Net margin -32.7%

Revenue ¥12.14B, +0,7% YoY; Operating income +18,7% YoY.

• ▍Revenue ¥12.14B, +0,7% YoY
• ▍Operating income +18,7% YoY
• ▍Net income +31,9% YoY
• ▍Free cash flow +84,2% YoY
• ▍Net margin 6.3%

Revenue ¥12.06B, −2,1% YoY; Operating income +133,2% YoY.

• ▍Revenue ¥12.06B, −2,1% YoY
• ▍Operating income +133,2% YoY
• ▍Net income +127,2% YoY
• ▍Free cash flow +117,0% YoY
• ▍Net margin 4.8%

Revenue ¥12.32B, +2,4% YoY; Operating income −213,8% YoY.

• ▍Revenue ¥12.32B, +2,4% YoY
• ▍Operating income −213,8% YoY
• ▍Net income −199,3% YoY
• ▍Free cash flow −271,3% YoY
• ▍Net margin -17.2%

Revenue ¥12.04B, −6,8% YoY; Operating income −99,7% YoY.

• ▍Revenue ¥12.04B, −6,8% YoY
• ▍Operating income −99,7% YoY
• ▍Net income −163,1% YoY
• ▍Free cash flow −685,7% YoY
• ▍Net margin -5.9%